Axcynsis Therapeutics

Singapore, Singapore · Founded 2022 · Privately Held (backing)

Developer of antibody-drug conjugate therapies designed for treating cancer. Axcynsis Therapeutics is based in Singapore, Singapore and was founded in 2022. Its last known valuation is $36.1 million. It has raised $21 million.

Last price · $/share
—
Implied valuation
$36.1M
Total raised
$21.0M
Last round
—

Who backs Axcynsis Therapeutics?

2 investors
InvestorType
Hapi Investment ManagementFund of funds
TIBS - Trinity funds—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Axcynsis Therapeutics investors

2 investors are on record for Axcynsis Therapeutics, including Hapi Investment Management and TIBS - Trinity funds.

Free account
More of Axcynsis Therapeutics with a free account
  • ·Watch Axcynsis Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 2 firms already write checks for companies like Axcynsis Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View